Now, the therapeutic horizon is extending further: researchers and clinicians are evaluating ultra-long-acting GLP-1 depots that could be dosed once monthly or even quarterly
Im not a doctor
as those pass, more similar biologics can enter the market.[8] Tirzepatide, being newer, remains under stronger patent protection for longer, which is one reason the mounjaro injection price in India is still much higher than generic semaglutide Eli Lillys patent has not yet expired
Exploring the science behind obesity and addiction Obesity and addiction share a surprising connection rooted in brain science
Dietary intake, glucose metabolism and sex hormones in women with polycystic ovary syndrome (PCOS) compared with women with non-PCOS-related infertility
Evaluating the differential expression of miR-146a, miR-222, and miR-9 in matched serum and follicular fluid of polycystic ovary syndrome patients: profiling and predictive value